School of Molecular and Cellular Biology and Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.
Centre for Skin Sciences, School of Chemistry and Biosciences, Faculty of Life Sciences, University of Bradford, Bradford, United Kingdom.
PLoS Pathog. 2018 Sep 6;14(9):e1007276. doi: 10.1371/journal.ppat.1007276. eCollection 2018 Sep.
Merkel cell carcinoma (MCC) is an aggressive skin cancer with a high propensity for recurrence and metastasis. Merkel cell polyomavirus (MCPyV) is recognised as the causative factor in the majority of MCC cases. The MCPyV small tumour antigen (ST) is considered to be the main viral transforming factor, however potential mechanisms linking ST expression to the highly metastatic nature of MCC are yet to be fully elucidated. Metastasis is a complex process, with several discrete steps required for the formation of secondary tumour sites. One essential trait that underpins the ability of cancer cells to metastasise is how they interact with adjoining tumour cells and the surrounding extracellular matrix. Here we demonstrate that MCPyV ST expression disrupts the integrity of cell-cell junctions, thereby enhancing cell dissociation and implicate the cellular sheddases, A disintegrin and metalloproteinase (ADAM) 10 and 17 proteins in this process. Inhibition of ADAM 10 and 17 activity reduced MCPyV ST-induced cell dissociation and motility, attributing their function as critical to the MCPyV-induced metastatic processes. Consistent with these data, we confirm that ADAM 10 and 17 are upregulated in MCPyV-positive primary MCC tumours. These novel findings implicate cellular sheddases as key host cell factors contributing to virus-mediated cellular transformation and metastasis. Notably, ADAM protein expression may be a novel biomarker of MCC prognosis and given the current interest in cellular sheddase inhibitors for cancer therapeutics, it highlights ADAM 10 and 17 activity as a novel opportunity for targeted interventions for disseminated MCC.
默克尔细胞癌(Merkel cell carcinoma,MCC)是一种侵袭性皮肤癌,具有较高的复发和转移倾向。默克尔细胞多瘤病毒(Merkel cell polyomavirus,MCPyV)被认为是大多数 MCC 病例的致病因素。MCPyV 小肿瘤抗原(small tumour antigen,ST)被认为是主要的病毒转化因子,然而,将 ST 表达与 MCC 高度转移性联系起来的潜在机制尚未完全阐明。转移是一个复杂的过程,需要几个离散的步骤才能形成继发性肿瘤部位。癌症细胞转移能力的一个重要特征是它们与相邻肿瘤细胞和周围细胞外基质相互作用的方式。在这里,我们证明 MCPyV ST 表达破坏了细胞-细胞连接的完整性,从而增强了细胞分离,并暗示细胞脱落酶,解整合素和金属蛋白酶(A disintegrin and metalloproteinase,ADAM)10 和 17 蛋白在这个过程中起作用。抑制 ADAM 10 和 17 的活性降低了 MCPyV ST 诱导的细胞分离和迁移,表明它们的功能对于 MCPyV 诱导的转移过程至关重要。与这些数据一致,我们证实 ADAM 10 和 17 在 MCPyV 阳性原发性 MCC 肿瘤中上调。这些新发现表明细胞脱落酶是宿主细胞因子的关键因素,有助于病毒介导的细胞转化和转移。值得注意的是,ADAM 蛋白表达可能是 MCC 预后的一个新的生物标志物,鉴于目前对细胞脱落酶抑制剂在癌症治疗中的兴趣,它突出了 ADAM 10 和 17 活性作为针对 MCC 扩散的靶向干预的新机会。